CLINICAL RESEARCH: CARDIAC RHYTHM DISORDERS
Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation
Patrick T. Ellinor, MD, PhD,
Adrian F. Low, MB, BS,
Kristen K. Patton, MD,
Marisa A. Shea, RN and
Calum A. MacRae, MB, ChB, PhD*
Cardiac Arrhythmia Service and Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts
Manuscript received June 8, 2004;
revised manuscript received August 25, 2004,
accepted September 2, 2004.
* Reprint requests and correspondence: Dr. Calum A. MacRae, Cardiovascular Research Center, Massachusetts General Hospital, 149 13th Street, Charlestown, Massachusetts 02129 (Email: cmacrae{at}partners.org).
OBJECTIVES: We sought to characterize natriuretic peptide levels in a cohort of rigorously characterized subjects with lone atrial fibrillation (AF).
BACKGROUND: Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are sensitive biomarkers of cardiac contractile dysfunction. Both peptides have been reported to be elevated in cohorts with AF, but previous studies have included subjects with underlying structural heart disease. We studied these hormones in 150 subjects with lone AF.
METHODS: Study subjects had electrocardiographic evidence of at least one episode of AF and a structurally normal heart on echocardiography. Subjects were excluded if they had a history of a myocardial infarction, rheumatic heart disease, cardiomyopathy, significant valvular disease, hyperthyroidism, or hypertension that preceded the onset of AF. Control subjects were obtained from a healthy outpatient primary care population. Plasma pro-ANP and N-terminal pro-BNP (nt-pro-BNP) levels were determined using commercially available immunoassays.
RESULTS: A total of 150 serial subjects with lone AF were enrolled and studied, the majority during normal sinus rhythm. Median levels of nt-pro-BNP were significantly elevated in subjects with lone AF as compared with control subjects (166 vs. 133 fmol/ml, p = 0.0003). There was no significant difference in pro-ANP levels between subjects with lone AF and control subjects (1,730 vs. 1,625 fmol/ml, p = 0.90).
CONCLUSIONS: Discordant natriuretic peptide levels were observed in this homogeneous population of subjects with lone AF. This biomarker pattern, which is present even in sinus rhythm, may represent an underlying subclinical predisposition to this common arrhythmia.
|
Abbreviations and Acronyms
| | AF = atrial fibrillation | | ANP = atrial natriuretic peptide | | BNP = brain natriuretic peptide | | NP = natriuretic peptide |
|
This article has been cited by other articles:

|
 |

|
 |
 
S Kurl, M Ala-Kopsala, H Ruskoaho, T Makikallio, K Nyyssonen, O Vuolteenaho, J Sivenius, J T Salonen, and J A Laukkanen
Plasma N-terminal fragments of natriuretic peptides predict the risk of stroke and atrial fibrillation in men
Heart,
July 1, 2009;
95(13):
1067 - 1071.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Winkler, C. Wanner, C. Drechsler, J. Lilienthal, W. Marz, V. Krane, and for the German Diabetes and Dialysis Study Investi
Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients
Eur. Heart J.,
September 1, 2008;
29(17):
2092 - 2099.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Darbar, A. Hardy, J. L. Haines, and D. M. Roden
Prolonged signal-averaged P-wave duration as an intermediate phenotype for familial atrial fibrillation.
J. Am. Coll. Cardiol.,
March 18, 2008;
51(11):
1083 - 1089.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. B. Daniels and A. S. Maisel
Natriuretic Peptides
J. Am. Coll. Cardiol.,
December 18, 2007;
50(25):
2357 - 2368.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Cardinale, A. Colombo, M. T. Sandri, G. Lamantia, N. Colombo, M. Civelli, M. Salvatici, G. Veronesi, F. Veglia, C. Fiorentini, et al.
Increased Perioperative N-Terminal Pro-B-Type Natriuretic Peptide Levels Predict Atrial Fibrillation After Thoracic Surgery for Lung Cancer
Circulation,
March 20, 2007;
115(11):
1339 - 1344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rienstra, I. C. Van Gelder, M. P. Van den Berg, and D. J. Van Veldhuisen
Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP: reply
Europace,
February 1, 2007;
9(2):
148 - 148.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T Date, T Yamane, K Inada, S Matsuo, S Miyanaga, K Sugimoto, K Shibayama, I Taniguchi, and S Mochizuki
Plasma brain natriuretic peptide concentrations in patients undergoing pulmonary vein isolation
Heart,
November 1, 2006;
92(11):
1623 - 1627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Goetze, L. Friis-Hansen, J. F. Rehfeld, B. Nilsson, and J. H. Svendsen
Atrial secretion of B-type natriuretic peptide
Eur. Heart J.,
July 2, 2006;
27(14):
1648 - 1650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rienstra, I. C. Van Gelder, M. P. Van den Berg, F. Boomsma, and D. J. Van Veldhuisen
Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP
Europace,
July 1, 2006;
8(7):
482 - 487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Laukkanen, S. Kurl, M. Ala-Kopsala, O. Vuolteenaho, H. Ruskoaho, K. Nyyssonen, and J. T. Salonen
Plasma N-terminal fragments of natriuretic propeptides predict the risk of cardiovascular events and mortality in middle-aged men
Eur. Heart J.,
May 2, 2006;
27(10):
1230 - 1237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. T. Ellinor, A. F. Low, and C. A. MacRae
Reduced apelin levels in lone atrial fibrillation
Eur. Heart J.,
January 2, 2006;
27(2):
222 - 226.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|